Jci_page_head_homepage_01 Jci_page_head_homepage_02
Masahisa Jinushi, Yukoh Nakazaki, Michael Dougan, Daniel R. Carrasco, Martin Mihm, Glenn Dranoff
Published in Volume 117, Issue 7
J Clin Invest. 2007; 117(7):1902–1913 doi:10.1172/JCI30966
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 4
GM-CSF contributes to Treg homeostasis through MFG-E8.

(A) Engineered peritoneal macrophages were exposed to apoptotic thymocytes and cocultured with wild-type syngeneic splenocytes. FoxP3-expressing Tregs were assayed by flow cytometry. Numbers refer to the percentage of cells within an indicated gate. (B) Blocking antibodies to TGF-β or MHC class II were added to the coculture of apoptotic cell–loaded macrophages and syngeneic splenocytes. (C) Supernatants from macrophages exposed to apoptotic cells were assayed for chemotactic activity against CD4+CD25+ and CD4+CD25 T cells. Blocking antibodies against CCL22 or control isotype were added as indicated. (D) Splenocytes were analyzed for CD4, CD25, and FoxP3 expression. Results are representative of 2 to 6 experiments.